Lidco Group (LID)

 

LID Share PerformanceMore

52 week high8.6500 16/05/16
52 week low5.2500 23/08/16
52 week change -1.0000 (-12.12%)
4 week volume7,547,853 31/03/17

Media for (LID)

Presenter: Matt Sassone
28/03/2017
Presenter: Matt Sassone
15/02/2017

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Award of share options/ director dealing

RNS Number: 7731C LiDCO Group Plc 20 April 2017 LiDCO Group Plc ("LiDCO" or the "Company") Award of share options/director dealing LiDCO (AIM: LID), the hemodynamic monitoring company, announces that t he Board has yesterday, 19 th April 2017, finalised a grant of options ("Options") to Mr Sassone, CEO, to subscribe for new ordinary shares of 0.5p ...

Director Deals - LiDCO Group PLC (LID)

Peter Grant, Non Executive Director, bought 500,000 shares in the company on the 31st March 2017 at a price of 7.32p. The ...

Investor presentation

RNS Number: 2338B LiDCO Group Plc 03 April 2017 LiDCO Group Plc ("LiDCO" or the "Company") Investor presentation LiDCO (AIM: LID), the hemodynamic monitoring company , announces that it will be presenting at the ShareSoc Growth Company Seminar in London on Tuesday 11 April 2017. ShareSoc is an organisation dedicated to supporting individual pr...

Director/PDMR Shareholding

RNS Number: 2504B LiDCO Group Plc 03 April 2017 LiDCO Group Plc ("LiDCO" or the "Company") Director/ PDMR Shareholding LiDCO (AIM: LID), the hemodynamic monitoring company, announces that on 31 March 2017, Mr Peter Grant, Non-Executive Director and Chairman Designate, purchased 500,000 ordinary shares of 0.5p nominal value ("Ordinary s...

LiDCO revenues rise

LiDCO's revenues rose by 8% to to 8.21m in the year to the end of January and the group made an adjusted profit before t...

Final Results

RNS Number: 6737A LiDCO Group Plc 28 March 2017 LIDCO GROUP PLC ("LiDCO" or the "Company" or the "Group") Final Results LiDCO (AIM: LID), the hemodynamic monitoring company , announces its audited Final Results for the year ended 31 January 2017. Financial highlights LiDCO product revenue (excluding third party products) up 14% to 6.76m (2...

Lidco - Final results

Notice of Results

RNS Number: 1729Z LiDCO Group Plc 13 March 2017 13 March 2017 L iDCO Group Plc ("LiDCO" or the "Company") Notice of Results LiDCO (AIM: LID), the hemodynamic monitoring company, will be reporting its final results for the year ended 31 January 2017 on Tuesday 28 March 2017. Matt Sassone, CEO and Paul Clifford, FD will be hosting a briefing for an...

Fundamental DataMore

P/E ratio80.556
EPS0.09
Dividend yield0 %

Latest discussion posts More

  • Re: It's 12th Feb 2015

    Yes, avoid. By any standard measure, a valuation between 1p and 2p would be appropriate.
    13-Apr-2016
    numberbiter
  • It's 12th Feb 2015

    Read today's RNS ~ sounds promising:- LiDCO said made good progress during the year. The company said it has increased the number of monitors in the market, grown its sales ...
    12-Feb-2015
    Norris107
  • Re: have also bought ...shorting?.

    ..heading for 4,000 ! * OFF TOPIC but important that all AIM investors understand the pitfalls of investing in stocks that are being shorted down to rock-bottom levels? So ...
    12-Jun-2014
    dickie3times

Users' HoldingsMore

Users who hold Lidco Group also hold..
LLOYDS GRP.24%
ROYAL MAIL21%
TESCO18%
AVIVA16%
WATCHSTONE GRP16%

Codes & Symbols

ISINGB0030546849
SymbolsLID, LSE:LID, LID.L, LID:LN, LON:LID, XLON:LID